EverSource Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1K Sell
1,390
-4,265
-75% -$57.5K ﹤0.01% 2425
2026
Q1
$78.3K Buy
5,655
+2,888
+104% +$40.2K ﹤0.01% 1577
2025
Q4
$38.8K Sell
2,767
-598
-18% -$8.39K ﹤0.01% 1925
2025
Q3
$47K Buy
3,365
+265
+9% +$3.81K ﹤0.01% 1759
2025
Q2
$46.6K Buy
3,100
+1,294
+72% +$18.5K ﹤0.01% 1667
2025
Q1
$23.8K Sell
1,806
-57
-3% -$786 ﹤0.01% 1603
2024
Q4
$29.4K Buy
1,863
+83
+5% +$1.25K ﹤0.01% 1433
2024
Q3
$28.3K Sell
1,780
-90
-5% -$1.45K ﹤0.01% 1313
2024
Q2
$30.4K Buy
1,870
+400
+27% +$5.73K ﹤0.01% 1314
2024
Q1
$21.6K Buy
1,470
+20
+1% +$292 ﹤0.01% 1326
2023
Q4
$20.2K Sell
1,450
-55
-4% -$735 ﹤0.01% 1229
2023
Q3
$20.1K Hold
1,505
– – ﹤0.01% 1124
2023
Q2
$19K Sell
1,505
-45
-3% -$525 ﹤0.01% 1173
2023
Q1
$17.6K Sell
1,550
-285
-16% -$3.08K ﹤0.01% 1126
2022
Q4
$19K Sell
1,835
-155
-8% -$1.67K ﹤0.01% 1082
2022
Q3
$20K Buy
1,990
+240
+14% +$2.56K ﹤0.01% 910
2022
Q2
$19K Buy
1,750
+435
+33% +$4.73K ﹤0.01% 846
2022
Q1
$15K Buy
1,315
+5
+0.4% +$57 ﹤0.01% 821
2021
Q4
$17K Buy
+1,310
New +$16.5K ﹤0.01% 755

Other funds holding RDY

EverSource Wealth Advisors's RDY Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 75% in Q2 2026, selling an estimated $57.5K and leaving 1,390 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2425.

EverSource Wealth Advisors first reported a position in RDY in Q4 2021 and has held it in 19 quarters since. The position peaked at $78.3K in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • EverSource Wealth Advisors held 1,390 shares of Dr. Reddy's Laboratories worth $20.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 4,265 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $57.5K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2425 holding.
  • EverSource Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Dr. Reddy's Laboratories position peaked at $78.3K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.